Although Setd2 was expressed at a similar level in mouse splenic Treg cells and intestinal Treg cells, we observed that SETD2 expression was increased in Treg cells from cancerous tissues compared with those from noncancerous tissues of CRC patients. Here, SETD2 is linked to colorectal carcinoma.